Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark.
AstraZeneca Nordic-Baltic, Oslo, Norway.
Prim Care Diabetes. 2021 Apr;15(2):262-268. doi: 10.1016/j.pcd.2020.09.006. Epub 2020 Oct 5.
To observe and report population demography, comorbidities, risk factor levels and risk factor treatment in a sample of individuals treated for type 2 diabetes in primary care in Norway, Sweden and Denmark.
Retrospective observational cohort using extraction of data from electronic medical records linked with national health care registries.
Sixty primary care clinics participated with annual cross-sectional data (2003 to 2015). In 2015 the sample consisted of 31,632 individuals. Mean age (64.5-66.8 years) and proportion of women (43-45%) were similar. The prevalence of cardiovascular disease in 2015 was 40.7%, 41.6% and 38.0% for Norway, Sweden and Denmark, respectively and 84% to 89% of patients were receiving a pharmacological anti-diabetic treatment. More Danish patients reached targets for HbA and LDL cholesterol, while more patients in Sweden and Denmark met the blood pressure target of <130/80 mmHg as compared to Norway.
In three comparable public primary health care systems we found a high prevalence of cardiovascular disease and differences in risk factor treatment and attainment of risk factor goals. With recent guideline changes there is potential for further prevention of diabetes complications in primary care in the future.
观察和报告在挪威、瑞典和丹麦的初级保健中接受 2 型糖尿病治疗的个体样本中的人口统计学、合并症、风险因素水平和风险因素治疗情况。
使用从电子病历中提取的数据,并与国家医疗保健登记处进行链接,进行回顾性观察性队列研究。
60 家初级保健诊所参与了年度横断面数据(2003 年至 2015 年)。2015 年样本由 31632 人组成。平均年龄(64.5-66.8 岁)和女性比例(43-45%)相似。2015 年挪威、瑞典和丹麦的心血管疾病患病率分别为 40.7%、41.6%和 38.0%,84%至 89%的患者接受了药物抗糖尿病治疗。丹麦患者的 HbA 和 LDL 胆固醇目标达标率更高,而瑞典和丹麦的患者血压目标<130/80mmHg 的达标率高于挪威。
在三个具有可比性的公共初级卫生保健系统中,我们发现心血管疾病的患病率很高,并且在风险因素治疗和风险因素目标达标方面存在差异。随着最近指南的改变,未来初级保健中预防糖尿病并发症的潜力更大。